tiprankstipranks
Trending News
More News >
Kirin Holdings Company Limited (JP:2503)
:2503

Kirin Holdings Company (2503) AI Stock Analysis

Compare
1 Followers

Top Page

JP

Kirin Holdings Company

(OTC:2503)

Rating:60Neutral
Price Target:
¥2,177.00
▲(5.37%Upside)
Kirin Holdings' overall stock score is primarily influenced by its solid financial performance, which is offset by bearish technical indicators and a high valuation. The company's ability to improve profitability margins and convert cash flows effectively will be crucial for enhancing its stock appeal. Despite strong financial fundamentals, market conditions suggest caution with potential oversold signals indicating some recovery potential.
Positive Factors
Business Expansion
Kirin is focusing on expanding its Health Science product mix within the Food & Beverage domain with beverages that boost immunity.
Health Science Focus
Kirin is focusing on Health Science as a key earnings driver, aiming to turn a loss into a significant profit by 2027.
Regional Growth
Growth in the APAC region is expected due to improvements in beverage profit structures and the expansion of Blackmores and FANCL brands.
Negative Factors
Disappointing Earnings
Kirin reported a disappointing Q1 top line whichever way it was cut, with operating profit coming in well below expectations.
Market Struggle
Kyowa Hakko Bio’s continued struggle is worrisome amid softness in the amino acid market with limited visibility on turnaround.
Pharmaceutical Challenges
The pharmaceutical segment is likely to see further declines in profitability as Kirin increases R&D spending to expand its drug pipeline.

Kirin Holdings Company (2503) vs. iShares MSCI Japan ETF (EWJ)

Kirin Holdings Company Business Overview & Revenue Model

Company DescriptionKirin Holdings Company, Limited produces and sells alcoholic beverages, soft drinks, pharmaceuticals, and other related products in Japan and internationally. It operates through four segments: Japan Beer and Spirits Businesses, Japan Non-Alcoholic Beverages Business, Oceania Integrated Beverages Business, and Pharmaceuticals Business. The company's products include beer, happo-shu, wine, whiskey, spirits, soft drinks, dairy products, fruit juices, and other products. It also produces and sells pharmaceutical products, biochemical products, and other products. In addition, the company engages in the factories and theme park businesses; management and operation of a chain of Kirin City beer pubs; and manufacture and sale of amino acids and nucleic acids for pharmaceutical and industrial use bulk pharmaceuticals, as well as margarine, jams, and honey. Further, it is involved in the manufacture and sale of Coca-Cola products and other soft drinks, and sake and other food products; as well as manufacture and supply of Four Roses bourbon; and acts as an insurance agent. The company was formerly known as Kirin Brewery Company, Limited and changed its name to Kirin Holdings Company, Limited in July 2007. Kirin Holdings Company, Limited was founded in 1885 and is headquartered in Tokyo, Japan.
How the Company Makes MoneyKirin Holdings Company generates revenue through multiple streams, with its core income derived from the production and sale of beverages, including alcoholic beverages like beer and wine, as well as non-alcoholic beverages such as juices and soft drinks. The company also earns substantial revenue from its pharmaceutical division, where it develops and sells pharmaceuticals and health-related products. Kirin's diversified portfolio allows it to benefit from various markets, and its strategic partnerships and joint ventures, such as those with other beverage companies and pharmaceutical firms, enhance its market reach and profitability. Additionally, Kirin invests in innovative product development and marketing strategies to maintain and grow its customer base, contributing to its overall earnings.

Kirin Holdings Company Financial Statement Overview

Summary
Kirin Holdings demonstrates a commendable financial position with steady revenue and profit growth, efficient operations, and robust cash flows. Despite healthy operational metrics, the company should focus on enhancing net margins and free cash flow conversion to improve financial health further.
Income Statement
76
Positive
Kirin Holdings exhibits a strong financial performance with its TTM gross profit margin at 45.77% and a net profit margin of 2.38%. The company shows a healthy revenue growth rate of 6.03% from 2024 to 2025, indicative of a solid market position. The EBIT margin at 7.87% and EBITDA margin at 12.77% for TTM highlight operational efficiency but suggest room for improvement in net profitability. Overall, the income statement reflects steady revenue and profit growth, though with modest net income margins.
Balance Sheet
68
Positive
Kirin Holdings maintains a balanced financial structure with a debt-to-equity ratio of 0.94, indicating manageable leverage. The return on equity (ROE) is 5.13%, showing moderate returns for shareholders. An equity ratio of 33.89% indicates a fair amount of shareholder equity compared to total assets. While the company has a robust asset base, its rising debt levels warrant careful monitoring to avoid increased financial risk.
Cash Flow
72
Positive
The cash flow statement reveals a positive trajectory with a free cash flow growth rate of 54.44% from 2024 to 2025. The operating cash flow to net income ratio of 3.76 demonstrates strong cash generation ability relative to earnings. However, with a free cash flow to net income ratio of 0.31, there is room for improvement in translating profits into free cash flows. The company showcases healthy operational cash flows but faces challenges in converting those effectively into free cash flow.
Breakdown
TTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
2.38T2.34T2.13T1.99T1.82T1.85T
Gross Profit
1.09T1.07T920.79B905.71B822.84B803.88B
EBIT
187.52B125.34B201.21B116.02B106.66B102.92B
EBITDA
304.46B253.42B294.80B260.36B150.70B189.23B
Net Income Common Stockholders
56.65B58.21B112.70B111.01B59.79B99.84B
Balance SheetCash, Cash Equivalents and Short-Term Investments
122.52B127.19B140.34B96.44B157.40B169.62B
Total Assets
3.26T3.35T2.87T2.54T2.47T2.46T
Total Debt
1.03T857.57B733.08B523.12B551.47B642.64B
Net Debt
912.07B738.95B601.68B435.06B401.98B480.98B
Total Liabilities
1.87T1.82T1.44T1.29T1.32T1.36T
Stockholders Equity
1.11T1.18T1.13T980.02B894.18B838.58B
Cash FlowFree Cash Flow
17.66B62.26B89.40B37.08B132.97B71.81B
Operating Cash Flow
213.20B242.84B203.21B135.56B219.30B164.84B
Investing Cash Flow
-309.44B-329.38B-226.09B-10.40B-56.41B-115.98B
Financing Cash Flow
81.62B58.13B35.91B-167.84B-180.46B-52.47B

Kirin Holdings Company Technical Analysis

Technical Analysis Sentiment
Negative
Last Price2066.00
Price Trends
50DMA
2100.07
Negative
100DMA
2046.48
Positive
200DMA
2081.81
Negative
Market Momentum
MACD
-11.37
Positive
RSI
44.53
Neutral
STOCH
43.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2503, the sentiment is Negative. The current price of 2066 is below the 20-day moving average (MA) of 2080.78, below the 50-day MA of 2100.07, and below the 200-day MA of 2081.81, indicating a bearish trend. The MACD of -11.37 indicates Positive momentum. The RSI at 44.53 is Neutral, neither overbought nor oversold. The STOCH value of 43.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:2503.

Kirin Holdings Company Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
65
Neutral
$8.89B15.014.75%203.76%3.54%-2.49%
60
Neutral
$1.68T29.604.91%3.58%9.00%-57.41%
$19.84B16.337.40%2.37%
$24.90B54.818.89%1.06%
$6.09B18.246.71%2.98%
$3.93B110.982.87%0.68%
$9.93B17.027.61%2.26%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:2503
Kirin Holdings Company
2,066.00
-78.40
-3.66%
ASBRF
Asahi Group Holdings
13.44
1.28
10.53%
AJINF
Ajinomoto Co
25.42
6.93
37.48%
MEJHF
Meiji Holdings Co
22.24
0.32
1.46%
SOOBF
Sapporo Holdings
50.53
15.11
42.66%
STBFF
Suntory Beverage & Food
32.32
-2.89
-8.21%

Kirin Holdings Company Corporate Events

Kirin Holdings Strengthens Board with New Independent Directors
Feb 27, 2025

Kirin Holdings Company has announced the nomination of several experienced individuals as Independent Non-executive Directors and Audit & Supervisory Board Members, aiming to enhance its corporate governance and strategic oversight. The newly appointed directors bring extensive expertise in areas such as pharmaceuticals, international business, corporate governance, and legal affairs, which are expected to contribute to the company’s growth and value enhancement, particularly in the health science domain.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.